In this interview, we talk with Professor Tonia Vincent (Centre for Osteoarthritis Pathogenesis, University of Oxford, Oxford, UK) around how the therapeutic landscape in OA is changing.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
The presentation entitled ‘OA: New Horizons for Therapy.’ was given at the ACR Convergence, 3-9 November 2021.
Questions
- How are new delivery systems for osteoarthritis drugs opening new treatment possibilities? (0:16)
- What other novel approaches are in early stage clinical development? (1:50)
Disclosures:Â Tonia Vincent discloses ad hoc consultancy for Benevolent AI and academic support for STEpUP OA from: Novartis, Fidia, Galapagos, Biosplice, and Pfizer.
Support:Â Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the virtual ACR Convergence 2021.
